Dr. Anna Catania
Biography & Research Background
Anna Catania, MD, is affiliated with the Division of Internal Medicine at IRCCS Ospedale Maggiore, Milano, Italy, and is also associated with Zengen Inc. as a patent co-inventor. Dr. Catania has been instrumental in characterizing the antimicrobial and immunomodulatory properties of KPV, demonstrating that KPV and its dimeric forms possess candidacidal and antibacterial properties against Staphylococcus aureus and Candida albicans without the immunosuppressive side effects typical of other anti-inflammatory drugs. Anna Catania is being referenced as one of the leading scientists involved in the research and development of KPV. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Anna Catania is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Anna Catania is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.